Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Afnan

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Human Fertility (Cambridge, England)|October 10, 2001
Blastocyst transfer for patients with multiple assisted reproduction treatment failures: preliminary experienceD Sakkas, G Percival, Y D'Arcy, et al.
Fertility and Sterility|August 16, 2001
Validity of comparisons?S Papaionnou, M Afnan, B Ola, et al.
Fertility and Sterility|October 30, 2001
The use of repeat hysterosalpingographyS Papaioannou, M Afnan, A Coomarasamy, et al.
Human Reproduction (Oxford, England)|March 16, 2004
A postal survey of hydrosalpinx management prior to IVF in the United KingdomN Hammadieh, M Afnan, J Evans, et al.
Acta Obstetricia Et Gynecologica Scandinavica|February 16, 2002
Cost-effectiveness of recombinant versus urinary follicle stimulating hormone; whose point of view?B Ola, M Afnan, K Sharif, et al.
Fertility and Sterility|May 1, 1996
Transmyometrial embryo transfer after difficult immediate mock transcervical transferK Sharif, M Afnan, W Lenton, et al.
Obstetrics and Gynecology|November 9, 2002
Spontaneous disappearance of a normal adnexa associated with a contralateral polycystic-appearing ovaryO Olufowobi, O Sorinola, M Afnan, et al.
Human Reproduction (Oxford, England)|December 1, 2001
Should ICSI be the treatment of choice for all cases of in-vitro conception? Considerations of fertilization and embryo development, cost effectiveness and safetyB Ola, M Afnan, K Sharif, et al.
Human Reproduction (Oxford, England)|March 1, 1995
Ovarian response in consecutive cycles of ovarian stimulation in normally ovulating womenN A Ahmed Ebbiary, C Morgan, K Martin, et al.
Human Reproduction (Oxford, England)|November 7, 1998
Reducing the dose of gonadotrophin-releasing hormone agonist on starting ovarian stimulation: effect on ovarian response and in-vitro fertilization outcomeM Elgendy, M Afnan, R Holder, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Human Fertility (Cambridge, England)|October 10, 2001
Blastocyst transfer for patients with multiple assisted reproduction treatment failures: preliminary experienceD Sakkas, G Percival, Y D'Arcy, et al.
Fertility and Sterility|August 16, 2001
Validity of comparisons?S Papaionnou, M Afnan, B Ola, et al.
Fertility and Sterility|October 30, 2001
The use of repeat hysterosalpingographyS Papaioannou, M Afnan, A Coomarasamy, et al.
Human Reproduction (Oxford, England)|March 16, 2004
A postal survey of hydrosalpinx management prior to IVF in the United KingdomN Hammadieh, M Afnan, J Evans, et al.
Acta Obstetricia Et Gynecologica Scandinavica|February 16, 2002
Cost-effectiveness of recombinant versus urinary follicle stimulating hormone; whose point of view?B Ola, M Afnan, K Sharif, et al.
Fertility and Sterility|May 1, 1996
Transmyometrial embryo transfer after difficult immediate mock transcervical transferK Sharif, M Afnan, W Lenton, et al.
Obstetrics and Gynecology|November 9, 2002
Spontaneous disappearance of a normal adnexa associated with a contralateral polycystic-appearing ovaryO Olufowobi, O Sorinola, M Afnan, et al.
Human Reproduction (Oxford, England)|December 1, 2001
Should ICSI be the treatment of choice for all cases of in-vitro conception? Considerations of fertilization and embryo development, cost effectiveness and safetyB Ola, M Afnan, K Sharif, et al.
Human Reproduction (Oxford, England)|March 1, 1995
Ovarian response in consecutive cycles of ovarian stimulation in normally ovulating womenN A Ahmed Ebbiary, C Morgan, K Martin, et al.
Human Reproduction (Oxford, England)|November 7, 1998
Reducing the dose of gonadotrophin-releasing hormone agonist on starting ovarian stimulation: effect on ovarian response and in-vitro fertilization outcomeM Elgendy, M Afnan, R Holder, et al.
Pageof 6